News 2020-02-02
Announcement
All possible measures are taken to effectively safeguard the safety and health of all Porton employees in China, especially for our employees in Changshou Site. We are now concentrating resources to ensure that all ongoing projects are carried out in an orderly manner.
Porton Pharma Solutions Ltd.
Feb. 2nd, 2020
Nothing is Impossible For A Willing Heart!
Others
More
News 2025-04-16
Porton Advanced's End-to-End CDMO Solutions Accelerates IND Approval of Tasly's Innovative Dual-Targeting CAR-T Therapy
April 12, 2025 - Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD’s Innovative Dual-Targeting CAR-T Therapy, "P134 Cell Injection," which has received Investigational New Drug (IND) approval from China's National Medical Products Administration (NMPA) (Approval No.: 2025LP01030). This breakthrough CAR-T therapy is indicated for recurrent glioblastoma (GBM).
News 2025-04-11
Porton Newsletter - March 2025 Recap
Technical Enabling Services & Solutions Company Events ESG Marketing Activities
